autoimmun
disord
myelin
target
sever
unidentifi
virus
play
ancillari
role
possibl
molecular
mimicri
although
paradigm
led
import
progress
potenti
mechan
myelin
loss
neither
target
antigen
myelin
trigger
mechan
yet
identifi
leav
etiolog
still
unknown
anim
model
viral
demyelin
studi
show
jc
viru
jcv
polyomaviru
caus
progress
multifoc
leukoencephalopathi
pml
may
latent
normal
human
brain
suggest
anoth
possibl
host
immun
respons
target
protein
express
low
level
viral
dna
latent
central
nervou
system
cn
might
underli
focal
demyelin
diseas
ms
shift
autoimmun
latentviru
model
trivial
substitut
target
antigen
shift
would
expand
search
definit
laboratori
test
ms
could
lead
improv
therapeut
prevent
approach
year
autoimmun
theori
multipl
sclerosi
ms
etiolog
domin
field
origin
experiment
allerg
encephalomyel
eae
autoimmun
paradigm
go
back
nearli
year
work
river
colleagu
demyelin
follow
repeat
inject
normal
rabbit
brain
homogen
monkey
despit
occasion
dissent
neuropathologist
eae
gener
consid
suffici
clinic
patholog
similar
ms
provid
valid
model
develop
chronicrelaps
variant
experiment
allerg
encephalomyel
creae
ad
util
model
year
increasingli
sophist
immunolog
approach
dissect
aspect
eae
model
well
immun
dysregul
evid
ms
howev
cell
specif
myelin
basic
protein
mbp
found
circul
ms
patient
similar
cell
demonstr
healthi
individu
well
thu
question
persist
signific
immunolog
abnorm
antimyelin
reactiv
might
reflect
natur
immun
epiphenomena
result
myelin
breakdown
rather
caus
immunolog
abnorm
might
secondari
viru
recrudesc
recent
report
develop
white
matter
ion
sever
combin
immunodefici
scid
mice
follow
intracistern
inject
csf
mononuclear
cell
ms
patient
exacerb
support
pathogenet
role
cell
antigen
specif
remain
undefin
experiment
viral
concept
ms
etiopathogenesi
owe
much
eleg
studi
demyelin
mediat
immun
respons
viral
gene
product
delin
theiler
murin
encephalomyel
viru
tmev
model
howev
report
varieti
candid
ms
virus
isol
human
brain
remain
larg
unconfirm
laboratori
appropri
viral
model
involv
latenc
reactiv
human
viru
glial
cell
lack
recent
molecular
mimicri
hypothesi
viral
induct
autoimmun
chanc
crossreact
brain
antigen
led
multipl
viru
hypothesi
weaken
case
singl
specif
etiolog
viral
agent
brain
circumst
singleviru
etiolog
propos
ms
tend
face
skeptic
recept
purpos
present
review
entir
field
viru
persist
demyelin
make
case
particular
viru
major
caus
ms
rather
use
exampl
ubiquit
viru
tropism
glial
cell
illustr
valu
modifi
paradigm
investi
would
close
relat
human
polyomavirus
known
jc
viru
ucv
bk
viru
bkv
serolog
evid
suggest
jcv
bkv
natur
muitiipi
thought
ms
viru
could
one
two
basic
type
rare
agent
infect
rel
individu
frequent
pathogen
common
agent
infect
major
popul
perhap
signific
number
normal
brain
viru
express
host
respons
infect
immunocytochem
studi
laboratori
indic
perivascular
cellular
infiltr
appar
due
immunolog
reactiv
antigen
occur
model
fig
result
suggest
brain
glial
cell
around
vessel
trigger
lymphocyt
infiltr
although
human
pml
thought
characterist
lack
perivascular
mononuclear
cell
infiltr
underli
immunocompromis
condit
fact
perivascular
cuf
occur
eg
see
descript
case
richardson
simian
model
may
differ
regard
relev
pml
model
appar
macaqu
might
also
provid
model
mslike
diseas
induc
latent
viru
anim
carri
latent
infect
brain
balanc
viral
express
immun
tip
side
reactiv
abort
patholog
might
limit
immunemedi
destruct
glial
cell
primari
demyelin
thu
simian
immunodefici
viru
infect
macaqu
observ
regularli
possibl
occurr
mslike
sign
demyelin
attribut
mononuclear
cell
infiltr
respons
abort
infect
glial
cell
rather
twastag
process
delet
duplic
known
brain
adapt
gener
progress
multifoc
leukoencephalopathi
pml
type
viral
genom
capabl
replic
glial
cell
human
brain
rearrang
promot
enhanc
archetyp
form
circul
popul
becom
neurotrop
host
jcv
isol
obtain
pml
brainswer
uniqu
rearrang
none
ident
prototyp
strain
host
enzym
mediat
rearrang
unknown
diagram
modifi
j
vim
refer
product
infect
sivinduc
patholog
studi
polymeras
chain
reaction
pcr
frozen
section
brain
tissu
without
known
neurolog
diseas
shown
mani
half
brain
may
contain
low
level
jcv
dna
sequenc
amplifi
dna
fragment
brain
rearrang
regulatori
region
show
delet
follow
duplic
promot
enhanc
element
rather
stabl
archetyp
form
found
kidney
shed
urin
fig
addit
data
support
find
pcr
analysi
dna
extract
fix
brain
tissu
obtain
age
individu
without
pml
abl
detect
jcv
dna
onethird
brain
anoth
studi
pcr
use
detect
jcv
brain
human
immunodefici
viru
posit
individu
without
aid
cn
diseas
pml
brain
found
contain
jcv
dna
studi
jcv
dna
found
normal
brain
third
studi
brain
without
pml
found
harbor
jcv
dna
pcr
southern
blot
hybrid
analysi
two
posit
case
confirm
direct
clone
free
full
length
jcv
dna
infect
tissu
studi
ms
brain
show
evid
jcv
dna
addit
jcvposit
brain
also
posit
bkv
dna
much
lower
level
howev
fifth
studi
pcr
fail
detect
jcv
dna
prepar
either
ms
normal
brain
addit
studi
requir
ascertain
proport
nonpml
brain
polyomaviru
infect
state
viral
dna
individu
report
evid
viru
particl
jcv
express
brain
neuropatholog
chang
attribut
presenc
viral
dna
howev
anoth
studi
evid
jcv
dna
found
situ
hybrid
brain
elderli
patient
without
clinic
pml
small
foci
demyelin
note
find
could
reproduc
studi
alzheim
diseas
brain
tissu
pml
extrem
rare
complic
chronic
lymphocyt
leukemia
lymphoma
occur
approxim
aid
patient
find
jcv
dna
normal
brain
suggest
case
pml
almost
exclus
adult
diseas
may
repres
reactiv
latent
viral
dna
harbor
brain
follow
childhood
infect
pml
occur
aid
seem
like
two
main
factor
combin
promot
jcv
reactiv
first
immunosuppress
effect
infect
addit
sinc
tat
protein
transactiv
jcv
late
transcript
vitro
seem
like
tat
produc
infect
cn
transactiv
latent
jcv
brain
brain
tissu
doubli
infect
hiv
jcv
observ
sever
studi
howev
sinc
tat
regulatori
protein
express
prior
viral
replic
hiv
particl
need
present
tat
express
furthermor
appar
requir
superinfect
jcvcontain
glial
cell
hiv
sinc
singl
hivinfect
cell
transactiv
mani
uninfect
bystand
human
brain
could
provid
target
immunemedi
demyelin
thu
pml
repres
one
type
host
respons
latent
viru
infect
follow
immunosuppress
transactiv
quit
anoth
host
respons
latent
viru
might
involv
strictli
limit
viral
antigen
express
combin
hyperact
immun
respons
cn
viral
antigen
could
lead
demyelin
diseas
latentviru
model
viral
protein
possibl
cellular
protein
aberrantli
express
provid
antigen
target
addit
degen
chang
latent
infect
cell
lead
cell
death
antigen
releas
exclud
like
continuum
latent
infect
remain
entir
quiescent
one
hand
progress
clinic
definit
demyelin
diseas
exampl
primari
demyelin
without
clinic
ms
discov
routin
patholog
studi
autopsi
abnorm
neuroimag
suggest
subclin
ms
found
healthi
ident
twin
unaffect
sibl
ms
patient
well
older
adult
would
determin
whether
latent
viru
infect
remain
entir
benign
erupt
chronic
demyelin
diseas
ms
precis
mechan
trigger
jcv
bkv
express
kidney
tissu
lead
viru
excret
certain
condit
eg
late
pregnanc
immunosuppress
yet
understood
nevertheless
possibl
suggest
varieti
factor
capabl
influenc
viru
express
human
glial
cell
follow
like
factor
would
includ
intrins
ie
genet
host
viru
extrins
eg
environment
influenc
host
immun
respons
genet
host
anim
model
document
import
influenc
host
genet
determin
outcom
viru
infect
genet
influenc
like
includ
determin
specif
type
strength
immun
respons
may
turn
control
sever
extent
primari
infect
thu
extent
latenc
tissu
eg
kidney
spleen
bone
marrow
brain
immunogenet
aspect
ms
understood
context
well
context
autoimmun
mbp
genet
viru
least
two
distinct
genotyp
jcv
circul
human
popul
two
type
jcv
unit
state
term
type
type
identifi
dna
code
region
sequenc
data
pml
isol
also
present
europ
date
cell
contact
postul
tmev
model
analog
predict
deriv
macaqu
model
latent
polyomaviru
infect
one
found
asian
popul
dna
sequenc
differ
jcv
type
silent
ie
caus
typespecif
amino
acid
substitut
thu
capsid
protein
two
type
jcv
antigen
similar
type
virus
serolog
distinguish
howev
typespecif
amino
acid
chang
predict
cterminu
tantigen
might
function
signific
analog
tantigen
cterminu
jcv
tantigen
may
contain
hostrang
function
possibl
exist
distinct
type
jcv
characterist
northern
europ
asia
suggest
differ
type
viru
circul
european
japanes
popul
might
contribut
contrast
clinic
present
ms
addit
immunogenet
differ
asian
popul
previous
invok
small
dna
tumor
virus
polyomavirus
propens
integr
host
cell
dna
transform
oncogen
effect
mediat
subsequ
viral
oncogen
tantigen
express
viral
agent
integr
dna
scatter
glial
host
cell
earli
life
perhap
earli
brain
develop
thu
pass
daughter
cell
host
cell
mitosi
readi
explan
multifoc
infect
multifoc
lesion
would
provid
howev
free
viral
genom
could
also
lineal
pass
daughter
cell
viral
replic
neg
regul
cisact
mechan
restrict
per
cell
gener
focu
infect
would
repres
progeni
singl
infect
precursor
cell
cellular
gene
flank
insert
site
could
influenc
viral
express
turn
viral
promot
enhanc
could
alter
express
nearbi
cellular
gene
site
cleavag
circular
viral
genom
bp
jcv
would
import
interrupt
either
regulatori
region
viral
earli
code
region
would
preclud
product
intact
tantigen
truncat
polypeptid
might
howev
suffici
provid
antigen
target
glial
cell
assum
viru
latent
adult
brain
may
acquir
primari
infect
earli
life
possibl
transplacent
mother
reactiv
viru
pregnanc
unfortun
primari
infect
child
difficult
pinpoint
lack
known
diseas
symptom
identifi
seroconvers
matern
reactiv
shed
viru
urin
asymptomat
well
time
durat
site
primari
infect
well
magnitud
result
viremia
import
determin
whether
extent
viru
penetr
develop
brain
establish
latenc
influenc
eventu
outcom
viral
latenc
gener
given
viru
load
earlier
brain
develop
seed
occur
greater
number
daughter
cell
viral
genom
could
lineal
pass
true
whether
viral
dna
integr
host
cell
dna
free
viru
replic
synchron
cell
dna
mitosi
cell
type
target
brain
infect
although
jcv
grow
best
human
fetal
glial
cell
glial
cell
exclus
target
jcv
infect
vivo
infect
kidney
spleen
bone
marrow
well
document
within
brain
cell
type
may
involv
abort
granul
cell
infect
observ
cerebellar
pml
cell
type
infect
includ
microgli
cell
brain
endotheli
cell
jcv
infect
observ
umbil
vein
endotheli
cell
cultur
vascular
endotheli
cell
neonat
infect
hamster
brain
sinc
astrocyt
endfeet
contact
endotheli
cell
brain
microvasculatur
infect
brain
endotheli
cell
follow
earli
viremia
would
provid
avenu
agent
come
circul
reach
astrocyt
replic
infect
surround
oligodendrocyt
macaqu
pml
brain
show
sever
isol
cluster
oligodendrocyt
around
infect
astrocyt
fig
although
interpret
possibl
uniqu
array
best
explain
direct
passag
viru
central
locat
astrocyt
surround
oligodendrocyt
contact
human
pml
brain
cluster
enlarg
oligodendrocyt
describ
earliest
recogniz
microscop
lesion
creat
demyelin
foci
pinhead
size
usualiy
millimet
mm
diamet
sometim
small
mm
lesion
small
blood
vessel
often
seen
although
consist
perivascular
locat
prove
giant
astrocyt
pml
lesion
observ
cellular
process
attach
wall
adjac
blood
vessel
one
studi
intracytoplasm
cluster
jcv
particl
observ
electron
microscopi
infect
astrocyt
sometim
near
foot
process
might
pass
suscept
oligodendrocyt
although
late
stage
diseas
intracytoplasm
particl
also
interpret
earli
step
astrocyt
infect
virion
taken
surround
cell
debri
presenc
small
cluster
infect
oligodendrocyt
human
pml
brain
interpret
one
follow
way
firstli
characterist
pinpoint
foci
demyelin
b
figur
cluster
simian
viru
infect
oligodendrocyt
surround
infect
astrocyt
macaqu
brain
note
immunostain
astrocyt
process
extend
infect
oligodendrocyt
arrowhead
smaller
group
infect
oligodendrocyt
seen
locat
adjac
section
indic
infect
cell
surround
astrocyt
side
x
b
similar
cluster
anoth
section
lmmunostain
monoclon
antibodi
capsid
protein
biotinyl
goat
antibodi
mous
igg
follow
peroxidas
conjug
streptavidin
describ
counterstain
x
earli
pml
could
result
cytolysi
cluster
oligodendrocyt
infect
contact
infect
astrocyt
length
process
central
astrocyt
would
determin
diamet
earli
focu
infect
thu
extent
lesion
mm
infect
astrocyt
could
receiv
viru
infect
endotheli
cell
although
endotheli
cell
infect
well
recogn
possibl
rout
viru
penetr
brain
must
emphas
direct
evid
polyomaviru
transfer
along
pathway
lack
present
scheme
work
hypothesi
secondli
cluster
infect
glial
cell
could
aris
viru
pass
daughter
cell
common
infect
glial
precursor
cell
prolifer
could
ocn
free
integr
viru
size
cluster
would
determin
stage
develop
infect
initi
occur
effici
viral
minichromosom
persist
replic
thirdli
cluster
infect
cell
might
aris
infect
extracellular
viru
releas
lyse
cell
diffus
local
latter
possibl
seem
less
like
recur
featur
spread
beyond
coalesc
lesion
within
brain
featur
limit
earli
lesion
earli
diseas
environment
factor
modul
viral
host
genet
determin
could
includ
coinfect
close
relat
virus
may
influenc
immun
respons
pathogen
viru
case
jcv
would
includ
variou
serotyp
bkv
exist
distinct
serotyp
bk
viru
confirm
dna
sequenc
comparison
wildtyp
bkv
dun
variant
known
bkv
bkv
infect
probabl
modul
immun
respons
potenti
crossreact
jcv
amino
acid
sequenc
ident
bkv
strain
compris
bkv
strain
one
seri
urinari
isol
lack
primari
antigen
epitop
wild
type
bkv
capsid
bkv
db
strain
one
potenti
crossreact
bkv
serotyp
associ
jcv
infect
order
two
infect
acquir
might
significantli
influenc
jcv
immunoregul
gener
antibodi
bkv
acquir
popul
younger
age
jcv
revers
usual
order
infect
ie
acquisit
jcv
infect
bkv
might
influenc
strength
specif
immun
respons
jcv
bkv
cellular
immun
respons
jcv
bkv
virion
protein
tantigen
studi
littl
human
popul
due
lack
antigen
role
retrovirus
late
region
transactivut
abil
tat
transactiv
jcv
late
region
promot
suggest
may
play
direct
role
viral
reactiv
lead
induct
pml
aid
immunosuppress
alon
fact
tat
protein
stronger
activ
jcv
late
region
transcript
tantigen
two
act
synergist
potenti
role
tat
modul
jcv
antigen
express
latenc
ie
prior
dna
replic
absenc
capsid
protein
synthesi
remain
explor
noteworthi
infect
promot
mslike
diseas
prior
onset
clinic
aid
phenomenon
might
direct
result
brain
infect
indirect
effect
mediat
activ
anoth
latent
viru
latter
patient
might
repres
group
abort
viral
reactiv
suffici
caus
neurolog
diseas
stop
short
activ
viral
replic
fatal
product
cn
infect
date
one
aid
patient
present
mslike
symptom
report
develop
pml
anoth
patient
whose
brain
biopsi
jcv
replic
detect
sihi
hybrid
although
pcr
reveal
bone
marrow
peripher
blood
lymphocyt
infect
jcv
note
howev
postul
ms
patient
show
hyperact
immun
respons
latent
viral
brain
antigen
patient
may
less
like
progress
product
viral
infect
brain
lack
antivir
cn
immun
respons
thu
case
mslike
demyelin
diseas
jcv
provid
antigen
target
progress
pml
influenc
infect
may
actual
less
like
would
ordinari
jcv
latenc
use
instruct
anim
model
immunemedi
demyelin
trigger
viral
antigen
cn
provid
theiler
murin
encephalomyel
viru
infect
anoth
w
elldevelop
model
provid
coronavirusinduc
demyelin
encephalomyel
rat
studi
pathogenesi
polyomavirus
cn
potenti
role
small
dna
virus
demyelin
diseas
four
differ
anim
model
avail
tabl
model
polyomaviru
cn
infect
includ
simian
pml
due
context
simian
aid
neonat
hamster
brain
infectjon
persist
jcv
brain
cell
ressetar
unpublish
data
note
ham
ster
brain
infect
current
provid
model
brain
tumor
induct
brain
endotheli
cell
infect
jcv
addit
experiment
manipul
like
requir
creat
model
immunemedi
demyelin
trigger
polyomaviru
antigen
hamster
glial
cell
transgen
mice
carri
jcv
earli
region
express
oligodendrocyt
show
dysmyelin
cn
second
gener
anoth
transgen
mous
model
sever
dysmyelin
occur
anim
carri
mous
polyoma
viru
tantigen
dna
express
primarili
astrocyt
find
point
toward
key
role
astrocyt
oligodendrocyt
support
myelin
format
mainten
data
avail
medic
disciplin
ms
neurolog
diseas
yet
etiopathogenesi
remain
mysteri
could
brain
infect
latent
viru
capabl
limit
reactiv
glial
cell
explain
wealth
data
exampl
polyomavirus
suggest
could
unfortun
knowledg
natur
histori
polyomaviru
infect
human
still
fragmentari
littl
data
avail
infect
relat
ms
although
jcv
first
cultur
character
primari
jcv
infect
human
never
identifi
therefor
imposs
studi
serolog
test
present
avail
indic
acquisit
appar
silent
initi
infect
wide
use
antibodi
assay
hemagglutin
inhibit
requir
larg
amount
viru
limit
suppli
due
difficulti
jcv
cultur
primari
human
fetal
glial
cell
singl
report
bkv
serolog
ms
reveal
associ
publish
inform
jcv
serolog
relat
ms
respect
patholog
systemat
comparison
lesion
develop
distribut
pml
ms
brain
never
report
howev
comparison
recogn
patholog
featur
diseas
suggest
interest
parallel
noteworthi
small
earli
foci
describ
pml
way
reminisc
earliest
ms
lesion
describ
lumsden
discuss
earli
ms
patholog
see
also
refer
relationship
mani
small
ms
plaqu
cours
vessel
consist
propos
rout
polyomaviru
entri
cn
onset
topolog
ms
lesion
may
defin
larg
part
distribut
viral
antigen
along
pathway
taken
viru
leav
circul
enter
brain
path
could
within
divid
cell
cell
contact
recent
neuroimag
data
suggest
disturb
bloodbrain
barrier
without
clinic
symptom
initi
event
develop
new
demyelin
lesion
relaps
remit
ms
find
emphas
role
endothelium
ms
lesion
pathogenesi
gener
interpret
term
eae
model
also
accommod
latentviru
model
fact
describ
jcv
infect
brain
endotheli
cell
product
infect
endotheli
cell
jcv
unusu
pml
abort
infect
hamster
endotheli
cell
tantigen
express
day
age
particularli
pronounc
follow
immunosuppress
treatment
cyclophosphamid
thu
initi
event
bloodbrain
barrier
ms
pathogenesi
accommod
viral
hypothesi
immun
respons
target
cell
parenchyma
follow
viral
reactiv
infect
endotheli
cell
nearbi
origin
postul
wisniewski
et
al
polyomavirus
involv
demyelin
diseas
best
known
dna
tumor
virus
anim
model
encourag
continu
search
virus
human
tumor
thu
three
possibl
outcom
jcv
latenc
human
brain
envis
see
fig
etiolog
role
jcv
pml
well
establish
outcom
fig
remain
specul
respect
tumorigenesi
jcv
interest
center
around
medulloblastoma
current
direct
evid
involv
jcv
human
tumor
howev
perspect
unexplain
report
ms
lesion
glioma
occupi
anatom
locat
may
chanc
occurr
report
pml
multipl
glioma
astrocytoma
coincid
also
interest
context
final
coincid
clinic
ms
pml
complet
report
associ
three
differ
outcom
latter
associ
occur
aid
epidem
combin
influenc
system
lupu
erythematosu
sle
corticosteroid
therapi
certain
case
ms
demyelin
lesion
observ
autopsi
could
distinguish
chronic
pml
latent
viru
distribut
multifoc
cn
express
modul
immun
respons
well
transactiv
factor
act
within
cell
could
explain
vari
clinic
cours
ms
view
evid
presenc
normal
brain
small
human
dna
virus
gliotrop
properti
provid
compel
argument
diseas
mechan
common
viru
latent
cn
white
matter
provok
uncommon
immunopatholog
respons
suscept
individu
along
recent
evid
coronaviru
sequenc
ms
brain
polyomaviru
find
emphas
relev
latentviru
model
demyelin
diseas
viru
latenc
cn
couid
essenti
precondit
onset
ms
patholog
ie
socal
ms
trait
aithough
number
differ
virus
may
eventu
implic
cn
latenc
remain
unclear
appar
immun
respons
singl
viru
cn
could
provok
diseas
divers
variabl
express
ms
interplay
genet
environment
factor
list
act
viral
infect
capabl
latenc
reactiv
could
explain
complex
unpredict
clinic
cours
ms
well
creae
model
latentviru
model
ms
pathogenesi
sever
conceptu
advantag
provid
mechan
multifoc
distribut
antigen
cn
without
requir
viral
replic
independ
cell
divis
infect
occur
earli
life
allow
regul
antigen
express
variabl
time
within
foci
potenti
modul
immun
respons
crossreact
viral
antigen
organ
outsid
cn
eg
antigen
bkv
primari
cn
agent
jcv
develop
highli
sensit
pcr
techniqu
tool
detect
ms
candid
virus
latent
human
brain
hand
even
mani
latent
infect
cell
destroy
immun
respons
cours
diseas
infect
cell
express
littl
antigen
therefor
escap
destruct
may
continu
harbor
detect
level
viral
dna
choic
paradigm
import
determin
rang
question
ask
turn
limit
answer
obtain
time
chang
paradigm
within
framework
eae
autoimmun
paradigm
come
signific
advanc
understand
pathogenesi
ms
promis
new
approach
treatment
much
remain
uncertain
year
intens
investig
still
definit
autoantigen
breakthrough
laboratori
diagnosi
effect
longterm
treatment
ms
approach
diseas
prevent
fuller
understand
diseas
could
lead
new
diagnost
laboratori
test
new
possibl
therapi
prevent
direct
ms
therapi
research
indic
latentviru
paradigm
would
combin
attack
affer
effer
arm
immun
respons
would
involv
inhibit
viral
reactiv
reduc
peripher
immunogen
stimulu
well
central
antigen
target
possibl
select
immunosuppress
direct
toward
cn
antivir
immun
respons
reduc
inflamm
without
provok
increas
antigen
express
clearli
solid
rational
use
antivir
agent
would
ensur
new
emphasi
develop
futur
test
final
resolut
seemingli
intract
ms
problem
aptli
describ
borrow
churchil
riddi
wrap
mysteri
insid
enigma
requir
framework
authent
paradigm
although
ms
frequent
describ
autoimmun
diseas
use
latentviru
paradigm
might
acceler
progress
emphas
avenu
research
narrowli
base
eae
autoimmun
paradigm
bypass
